SCHEMBL32686637

SCHEMBL32686637

CC(C)(C)OC(=O)N[C@H]1CC[C@H](Nc2cc(Cl)ncc2C=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 7/20 0.43
▸ KDM1A O60341 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CKS1B P61024 1/20 0.39
▸ SKP1 P63208 1/20 0.39
▸ SKP2 Q13309 1/20 0.39
▸ JAK1 P23458 5/20 0.39
▸ JAK2 O60674 2/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ CDK9 P50750 1/20 0.39
▸ DRD2 P14416 2/20 0.38
▸ CACNB4 O00305 1/20 0.38
▸ CACNA1A O00555 1/20 0.38
▸ CACNA1G O43497 1/20 0.38
▸ CACNG3 O60359 1/20 0.38
▸ CACNA1F O60840 1/20 0.38
▸ CACNA1H O95180 1/20 0.38
▸ CACNB3 P54284 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24950007 1.00 BTK (0.43) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL32686700 1.00 BTK (0.43) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL24950000 1.00 BTK (0.43) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL32686524 0.91 BTK (0.48) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL24949946 0.91 BTK (0.48) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL29492883 0.85 BTK (0.46) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL30578524 0.85 BTK (0.46) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL23301590 0.84 BTK (0.45) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL24950192 0.84 BTK (0.45) BTKKDM1AMAOBKMT2AL3MBTL1
SCHEMBL24950101 0.84 BTK (0.45) BTKKDM1AMAOBKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051677-B1 BICYCLIC NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF SALT-INDUCED KINASE SIK2 CANCER RESEARCH TECH LTD (GB) 2026-03-18 — — EP disclosed
Send feedback